'Cannot cut corners' in approving Covaxin: WHO

October 18, 2021 22:45

The World Health Organisation on Monday said it was expecting additional information from India's Bharat Biotech regarding its COVID-19 jab Covaxin, asserting that it "cannot cut corners" before recommending a vaccine for emergency use.

The global health agency also emphasized that it must evaluate a vaccine thoroughly to make sure it is "safe and effective".

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine's Emergency Use Listing.

In a series of tweets, the WHO said, "we are aware that many people are waiting for WHO's recommendation for Covaxin to be included in the #COVID-19 Emergency Use Listing, but we cannot cut corners - before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective."

It also said that Bharat Biotech has been submitting data to WHO on a rolling basis and WHO experts have reviewed these data.

"WHO is expecting one additional piece of information from the company today," it said.

"When the information provided addresses all questions raised, WHO and the Technical Advisory Group will complete the assessment and come to a final recommendation whether to grant EUL to the vaccine, it said.

The WHO said the timeframe for its EUL procedure is dependent on how quickly a company, producing the vaccine, is able to provide the data required for WHO to evaluate the vaccine's quality, safety, efficacy and suitability for low- and middle-income countries.

The WHO's tweet came a day after its chief scientist Soumya Swaminathan said that the agency's technical advisory group will meet on October 26 to consider the emergency use listing of India's Covaxin which is being used in the country's nationwide anti-COVID-19 vaccination programme.

"The technical advisory group will meet on Oct 26th to consider EUL for #Covaxin. @WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere," she said.

Bharat Biotech last month said it has submitted all data pertaining to Covaxin to the WHO for EUL and is awaiting feedback from the global health watchdog.

"#COVAXIN clinical trial data was fully compiled & available in June 2021. All data was submitted for EUL application to WHO in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback," it said in a tweet.

"We are diligently working with the WHO to obtain EUL at the earliest," the company added. -- PTI

« Back to LIVE

TOP STORIES

Preity Slams Rohit 'Fake News'

'I hold Rohit Sharma in very high regard & am a big fan of his, but I have NEVER DISCUSSED him in any interview.'

Two dead, seven missing as boat capsizes in Odisha's Mahanadi River

The incident took place when around 50 passengers hailing from Kharsia area in the neighbouring Chhattisgarh were returning in the boat after visiting a temple in Patharseni Kuda in Odisha's Bargarh district.

Rahul Or Dhoni? Who Batted Best? Vote!

Does Rahul get your vote? Or did you prefer Dhoni's cameo?

President Xi launches cyber warfare wing for Chinese military

The Information Support Force was regarded as the revised version of the PLA's Strategic Support Force, established in 2015 by the Chinese military to deal with space, cyber, political and electronic warfare to fight what was described...

Skipper Rahul delighted after LSG get 'it all right' vs CSK

Lucknow Super Giants skipper KL Rahul was chuffed to get most of his decisions right as he guided his team to a convincing eight-wicket victory over defending champions Chennai Super Kings in the IPL game in Lucknow on Friday.